Healthcare Experts Call for Asian Pneumococcal Conjugate Vaccine Push
This article was originally published in PharmAsia News
Executive Summary
Public health experts have called for wider use of pneumococcal conjugate vaccines, especially in Asia where growing incidence among the very young and older adults has combined with antibiotic resistance.
You may also be interested in...
China Overlooks Pneumonia Threat; Pfizer Sees Greater Opportunity For Prevenar In India
HONG KONG - Pneumonia is one of China's great killers but it only gets peripheral attention from health authorities, which presents a challenge for companies like Pfizer that are trying to draw interest for vaccines in emerging markets
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia 2014: Distribution, Manufacturing To The Fore
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.